Skip to content
GGG450450450

Drawing based on the label description. No photo yet.

“Micronized colestipol hydrochloride tablets are yellow, elliptical, imprinted with a "G" on one side and "450" on the other side”

G 450 pill

Pill with imprint G 450 is yellow, oval, 19 mm and has been identified as Colestipol Hydrochloride 1 g. It is used for high cholesterol, high triglycerides and heart disease. It is supplied by Physicians Total Care, Inc.

Colestipol Hydrochloride 1 g

Imprint
G 450
Strength
1 g
Used for
High cholesterol, high triglycerides and heart disease
Color
Yellow
Shape
Oval
Size
19 mm
Score
No score line
Form
Tablet
Manufacturer
Physicians Total Care, Inc
Drug class
Bile acid sequestrant
NDC
54868-0610, 59762-0450, 54868-0610-0, 54868-0610-1, 68151-4361, 68151-4361-1, 59762-0450-1

Source: the official drug label on DailyMed (US National Library of Medicine). Last checked .

Report a mistake

Please do not include personal health information. For questions about your medicine, ask a pharmacist.

All Colestipol Hydrochloride pills and guides

What is Colestipol Hydrochloride used for?

Colestipol Hydrochloride is used for high cholesterol, high triglycerides, heart disease and diarrhea.

Medicine type
Bile acid sequestrant
Official uses from the US prescribing label

Since no drug is innocuous, strict attention should be paid to the indications and contraindications, particularly when selecting drugs for chronic long-term use.

Colestipol hydrochloride tablets are indicated as adjunctive therapy to diet for the reduction of elevated serum total and LDL-C in patients with primary hypercholesterolemia (elevated LDL-C) who do not respond adequately to diet. Generally, colestipol hydrochloride tablets have no clinically significant effect on serum triglycerides, but with their use, triglyceride levels may be raised in some patients.

Therapy with lipid-altering agents should be a component of multiple risk factor intervention in those individuals at significantly increased risk for atherosclerotic vascular disease due to hypercholesterolemia. Treatment should begin and continue with dietary therapy (see NCEP guidelines). A minimum of six months of intensive dietary therapy and counseling should be carried out prior to initiation of drug therapy. Shorter periods may be considered in patients with severe elevations of LDL-C or with definite CHD.

According to the NCEP guidelines, the goal of treatment is to lower LDL-C, and LDL-C is to be used to initiate and assess treatment response. Only if LDL-C levels are not available, should the Total-C be used to monitor therapy. The NCEP treatment guidelines are shown below.

*Coronary heart disease or peripheral vascular disease (including symptomatic carotid artery disease). †Other risk factors for coronary heart disease (CHD) include: age (males: ≥45 years; female: ≥55 years or premature menopause without estrogen replacement therapy); family history of premature CHD; current cigarette smoking; hypertension; confirmed HDL-C <35 mg/dL (0.91 mmol/L); and diabetes mellitus. Subtract one risk factor if HDL-C is ≥60 mg/dL (1.6 mmol/L).

From the FDA-approved label on DailyMed (published Sep 02, 2026).

Doctors sometimes prescribe a medicine for other reasons too. If you are not sure what yours is for, ask your pharmacist.

Is this your pill? Check every detail

  • One side shows G and the other side shows 450.
  • It is yellow, oval, 19 mm.
  • Its score line and coating match the details on this page.
  • It came from a pharmacy package that names the same drug.

Ingredients

Active: Colestipol Hydrochloride

Inactive: Triacetin, Carnauba Wax, Hypromelloses, Magnesium Stearate, Povidone, Silicon Dioxide

Also distributed by

Carilion Materials Management, Mylan Pharmaceuticals Inc.

Pills that look similar but are different drugs

Same color and shape, different medicine. This is why the imprint matters.

Other Colestipol Hydrochloride pills